As the most commonly used marker for evaluating HCC, serum AFP showed an AUC of 0.927 (95% CI: 0.886–0.969) and 0.981 (95% CI: 0.966–0.997) to distinguish patients with cancer from CHB and normal individuals. Here, AFP is linked to hepatocellular carcinoma.